|IntelliCell BioSciences, Inc.|
460 Park Avenue
United States - Map
|Full Time Employees:||6|
IntelliCell BioSciences, Inc. operates as a regenerative medicine company in the United States. It develops and commercializes regenerative medicine using adult autologous stromal vascular fraction cells derived from the blood vessels in adipose tissue. The companys products are intended to treat various clinical conditions, such as aesthetic conditions, orthopedic and sports injuries, and pain, as well as cardiac, gastrointestinal, periodontal, and autistic disorders. It also focuses on undertaking clinical studies in partnership with universities and hospitals for osteoarthritis, gum regeneration, non-healing diabetic ulcers, multiple sclerosis, cartilage regeneration, tendon repair, facial lines and wrinkles, chronic migraine headache, bone regeneration, and hair regeneration indications. In addition, the company is involved in sourcing, selling, and distributing laboratory equipment and supplies, which are used in tissue processing activities. It also licenses its products in Canada, Australia, New Zealand, and Thailand. The company has a collaboration agreement with Hielscher Ultrasonics to develop closed processing system for cell therapy manufacturing. IntelliCell BioSciences, Inc. is based in New York, New York.
|Dr. Steven A. Victor M.D.,
Chairman, Chief Exec. Officer, Pres, Principal Accounting Officer, Treasurer and Sec.
|Mr. Leonard A. Mazur ,
Interim Chief Operating Officer, Director and Chairman of Compensation Committee
|Mr. Jonathan Schwartz ,
|Ms. Sarah R. Young ,
Director of Quality Assurance
|Mr. Frederick Frank CFA,
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|